Your browser doesn't support javascript.
loading
A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy.
Yoo, Seunghoon; You, Dae Hyuk; Lee, Jeongyoon; Hong, H Christian; Lee, Sung Jin.
Afiliação
  • Yoo S; Nune Eye Hospital, Seoul 06198, Republic of Korea.
  • You DH; Department of Statistics, College of Letters & Science, University of Wisconsin-Madison, Madison, WI 53715, USA.
  • Lee J; Brain and Cognitive Sciences Research Center, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea.
  • Hong HC; Department of Medicine and Medical Microbiology, School of Medicine, New Tokyo Medical College, Pohnpei FM 96941, Micronesia.
  • Lee SJ; Department of Ophthalmology, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul 04401, Republic of Korea.
Medicina (Kaunas) ; 59(1)2023 Jan 16.
Article em En | MEDLINE | ID: mdl-36676801
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article